title: [Chronic lymphatic leukemia and Hodgkin's disease].
authors.forename: J
authors.initials: J
authors.lastname: Calvo Villas
authors.forename: M
authors.initials: M
authors.lastname: Ramírez Sánchez
authors.forename: F
authors.initials: F
authors.lastname: Sicilia Guillén
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002699:Chlorambucil / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D002699:Chlorambucil; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D014740:Vidarabine; C024352:fludarabine; D011241:Prednisone